colistimethate sodium
UkraineDrugs containing this active substance
-
The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria when other treatment methods are ineffective or unacceptable.
Form: powder for injection solution or infusion solution
Active substance Dosage colistimethate sodium 1 000 000 IU ATC: J01XB01
Manufacturer: Xellia Pharmaceuticals ApS (full production cycle)
-
The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria when other treatment methods are ineffective or unacceptable.
Form: powder for injection solution or infusion solution
Active substance Dosage colistimethate sodium 2 000 000 IU ATC: J01XB01
Manufacturer: Xellia Pharmaceuticals ApS (full production cycle)
-
The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria. It is also used via inhalation for the treatment of chronic pulmonary infections in patients with cystic fibrosis.
Form: powder for solution for injection or inhalation
Active substance Dosage colistimethate sodium 1000000 IU ATC: J01XB01
Manufacturer: ALFASIGMA S.p.A. (manufacturing of finished dosage form, primary and secondary packaging, quality control and batch release)
-
The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria. It is also used in inhalation form to treat chronic pulmonary infections in patients with cystic fibrosis.
Form: powder for solution for injection or inhalation
Active substance Dosage colistimethate sodium 2000000 IU ATC: J01XB01
-
The drug is used to treat severe infections caused by certain Gram-negative bacteria. It is also prescribed in inhalation form for the treatment of chronic pulmonary infections in patients with cystic fibrosis.
Form: powder for solution for injection, infusion or inhalation
Active substance Dosage colistimethate sodium 1 000 000 IU ATC: J01XB01
Manufacturer: Xellia Pharmaceuticals ApS (manufacturing of unpackaged product, primary packaging)
-
The drug is used to treat severe infections caused by certain Gram-negative bacteria. It is also indicated for the treatment of chronic pulmonary infections in patients with cystic fibrosis.
Form: powder for solution for injection, infusion or inhalation
Active substance Dosage colistimethate sodium 2 000 000 IU ATC: J01XB01
Manufacturer: Xellia Pharmaceuticals ApS (manufacturing of unpackaged product, primary packaging)